Akshay Desai
Akshay Desai
Assistant Professor of Medicine, Harvard Medical School
Verified email at partners.org
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
21554*2012
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
12354*2017
Angiotensin–neprilysin inhibition versus enalapril in heart failure
JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
N Engl J Med 371, 993-1004, 2014
40662014
Strategies for multivessel revascularization in patients with diabetes
ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ...
New England journal of medicine 367 (25), 2375-2384, 2012
16882012
Spironolactone for heart failure with preserved ejection fraction
B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ...
N Engl J Med 370, 1383-1392, 2014
15832014
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L K°ber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
15232019
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
12862012
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ...
Circulation 131 (1), 34-42, 2015
5952015
Rehospitalization for heart failure: predict or prevent?
AS Desai, LW Stevenson
Circulation 126 (4), 501-506, 2012
5932012
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
New England Journal of Medicine 381 (17), 1609-1620, 2019
5122019
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
Circulation 131 (1), 54-61, 2015
5112015
Treatment of anemia with darbepoetin alfa in systolic heart failure
K Swedberg, JB Young, IS Anand, S Cheng, AS Desai, R Diaz, ...
New England Journal of Medicine 368 (13), 1210-1219, 2013
4642013
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials
AS Desai, JC Fang, WH Maisel, KL Baughman
Jama 292 (23), 2874-2879, 2004
4642004
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin‐converting enzyme inhibition in patients with chronic systolic heart failure: rationale forá…
JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
European journal of heart failure 15 (9), 1062-1073, 2013
3592013
PARADIGM-HF investigators and committees
JJ McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Englá…, 2014
3312014
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
AS Desai, JJV McMurray, M Packer, K Swedberg, JL Rouleau, F Chen, ...
European heart journal 36 (30), 1990-1997, 2015
3182015
Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
ET Kato, MG Silverman, O Mosenzon, TA Zelniker, A Cahn, RHM Furtado, ...
Circulation 139 (22), 2528-2536, 2019
2932019
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlledá…
B Greenberg, J Butler, GM Felker, P Ponikowski, AA Voors, AS Desai, ...
The Lancet 387 (10024), 1178-1186, 2016
2872016
Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial
SD Solomon, AR Rizkala, J Gong, W Wang, IS Anand, J Ge, CSP Lam, ...
JACC: Heart Failure 5 (7), 471-482, 2017
2452017
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone iná…
AS Desai, EF Lewis, R Li, SD Solomon, SF Assmann, R Boineau, ...
American heart journal 162 (6), 966-972. e10, 2011
2412011
The system can't perform the operation now. Try again later.
Articles 1–20